Our Board of Directors

Ms. Cayer has over twenty years of biotechnology and medical device experience. Most recently, she has in-licensed several drug candidates from large pharmaceutical companies and acquired the Idun subsidiary of Pfizer. She joined Conatus from Idun Pharmaceuticals, where she served as Vice President, Corporate Development. Ms. Cayer played a key role in the negotiations leading to the sale of Idun to Pfizer.

Prior to Idun, Ms. Cayer spent five years at Isis Pharmaceuticals where she served most recently as Vice President, Business Development and was responsible for new business development including drug licensing, technology licensing, drug discovery and development collaborations, and the creation of spinout opportunities. She led and executed multiple alliances with pharmaceutical and biotech companies including three drug discovery collaborations totaling over $100 million and two drug development/licensing partnerships totaling over $200 million. In addition, Ms. Cayer played a key role in the spinout of a new company and it's successful IPO.

Ms. Cayer previously held business development, marketing, engineering and operational management positions at Gensia, Inc. (Sicor), and Puritan Bennett (Tyco). She holds a Bachelor's degree in Bioengineering from University of California, San Diego.